The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| OPHTHOTECH CORP | COM | 683745103 | 83,703 | 1,798,906 | SH | OTR | 1,2 | 0 | 1,798,906 | 0 | |
| OPHTHOTECH CORP | COM | 683745103 | 11,830 | 254,237 | SH | SOLE | 254,237 | 0 | 0 | ||
| TRANSENTERIX INC | COM NEW | 89366M201 | 22,112 | 7,546,692 | SH | OTR | 1,2 | 0 | 7,546,692 | 0 | |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 108,570 | 2,585,607 | SH | OTR | 1,2 | 0 | 2,585,607 | 0 | |
| ENTELLUS MED INC | COM | 29363K105 | 76,421 | 3,489,533 | SH | OTR | 1,2 | 0 | 3,489,533 | 0 | |